Taysha Gene Therapies Earnings Preview
Portfolio Pulse from Benzinga Insights
Taysha Gene Therapies (NASDAQ:TSHA) is scheduled to release its quarterly earnings report on March 19, 2024, with an expected EPS of $-0.11. Despite past earnings misses, the company's stock has seen a significant increase, with a 173.66% rise over the last 52 weeks. Investors are hopeful for positive guidance for the next quarter.
March 18, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Taysha Gene Therapies is expected to report an EPS of $-0.11 for the upcoming quarter. Historical performance shows significant stock price movements post-earnings, with a 173.66% increase over the last year.
Given TSHA's historical performance, where stock price increased despite earnings misses, and the significant 52-week rise, the upcoming earnings report is highly relevant. Positive guidance could further boost investor confidence, potentially leading to an increase in stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100